SciClone Pharma (SCLN) Posts Mixed Q4 Results

April 1, 2011 6:33 AM EDT
SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) reported Q4 EPS of $0.08, $0.03 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $23.62 million versus the consensus estimate of $23.59 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings